Prescient Therapeutics develops personalised therapies to conquer cancer. It has a broad portfolio of well advanced assets developed with world-leading partners ...
INVESTOR PORTAL. Here you will find ASX announcements and share price data, along with other key company information. You can also subscribe for email updates ...
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) will present results of its Phase 1b study of PTX-100 in T-cell lymphomas during a poster presentation .
Missing: relations | Show results with:relations
PTX Metals Inc. creates shareholder value through the opportunistic acquisition and advancement of high-quality projects in prolific Ontario mining camps.
We are Partner Therapeutics · PTx is a commercial biopharmaceutical company committed to improving the lives of patients with cancer and other serious diseases.
Read the latest Company Report General news from Prescient Therapeutics Limited (ASX:PTX)
Apr 7, 2024 · Join Prescient Therapeutics CEO & MD Steven Yatomi-Clarke for an online investor briefing on Tuesday, 9 April at 2pm (AEST).
Missing: relations | Show results with:relations
Investors · Stock Information · Corporate Presentation · Financial Statements · Notice and Access · Cautionary Notes.
Missing: relations | Show results with:relations
Click here to view our investor centre ... Prescient Therapeutics is a clinical-stage oncology company developing personalised medicine approaches to cancer, ...
Mar 27, 2024 · This is "Reach Markets: Prescient Therapeutics (ASX: PTX) Investor Briefing Q&A - 25th March 2024 (RM)" by Reach Markets on Vimeo, ...